1. Home
  2. TPST vs XOS Comparison

TPST vs XOS Comparison

Compare TPST & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • XOS
  • Stock Information
  • Founded
  • TPST 2011
  • XOS 2016
  • Country
  • TPST United States
  • XOS United States
  • Employees
  • TPST N/A
  • XOS N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • XOS Construction/Ag Equipment/Trucks
  • Sector
  • TPST Health Care
  • XOS Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • XOS Nasdaq
  • Market Cap
  • TPST 33.0M
  • XOS 25.6M
  • IPO Year
  • TPST N/A
  • XOS N/A
  • Fundamental
  • Price
  • TPST $7.40
  • XOS $3.33
  • Analyst Decision
  • TPST Hold
  • XOS Buy
  • Analyst Count
  • TPST 3
  • XOS 5
  • Target Price
  • TPST $30.00
  • XOS $8.80
  • AVG Volume (30 Days)
  • TPST 241.4K
  • XOS 20.0K
  • Earning Date
  • TPST 08-07-2025
  • XOS 08-12-2025
  • Dividend Yield
  • TPST N/A
  • XOS N/A
  • EPS Growth
  • TPST N/A
  • XOS N/A
  • EPS
  • TPST N/A
  • XOS N/A
  • Revenue
  • TPST N/A
  • XOS $48,678,000.00
  • Revenue This Year
  • TPST N/A
  • XOS $1.45
  • Revenue Next Year
  • TPST N/A
  • XOS $27.16
  • P/E Ratio
  • TPST N/A
  • XOS N/A
  • Revenue Growth
  • TPST N/A
  • XOS N/A
  • 52 Week Low
  • TPST $5.35
  • XOS $2.73
  • 52 Week High
  • TPST $30.03
  • XOS $9.15
  • Technical
  • Relative Strength Index (RSI)
  • TPST 53.40
  • XOS 50.62
  • Support Level
  • TPST $7.06
  • XOS $3.00
  • Resistance Level
  • TPST $7.18
  • XOS $3.30
  • Average True Range (ATR)
  • TPST 0.26
  • XOS 0.09
  • MACD
  • TPST 0.02
  • XOS 0.04
  • Stochastic Oscillator
  • TPST 90.05
  • XOS 66.67

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

Share on Social Networks: